Pre-market Hot Trades in US Stocks
Silo Pharma is down 9.21% in pre-market trading. Based on recent news,
<ol>
<li>
On April 22, Silo Pharma announced that the company will diversify into the AI infrastructure sector. This move aims to seize opportunities in high-growth, transformative technologies to drive the current tech economy. Following the announcement, the stock price fell 7.67% in after-hours trading.
</li>
<li>
On April 22, Silo Pharma's CEO Eric Weisblum stated that the company's main therapeutic development portfolio includes SPC-15 for post-traumatic stress disorder and SP-26 for fibromyalgia and chronic pain. Although the company's expansion into technology is viewed positively, the market remains skeptical about its short-term profitability, leading to a decline in stock price.
</li>
<li>
On April 22, Silo Pharma's stock traded in a range of $0.22 to $1.18 over the past year. The closing price on Wednesday was $0.56, down 8.13%. The uncertainty regarding its future performance has increased selling pressure. The tech sector has shown volatility recently, and investors should exercise caution.
</li>
</ol>
Comfort Systems USA is up 7.29% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 23, Comfort Systems USA announced an increase in its quarterly dividend to $0.80 per share, up $0.10 from before. This move has boosted investor confidence, driving the stock price up. Source: Reuters
</li>
<li>
On April 23, Comfort Systems USA reported a first-quarter net income growth of 118.8% to $370.4 million, with revenue increasing 56.5% year-over-year to $2.87 billion. Strong financial performance has lifted market sentiment. Source: SEC announcement
</li>
<li>
On April 23, analysts maintained a &#34;Buy&#34; rating with a target price of $1,770.23, indicating a 2.7% upside from the current stock price. Analysts' positive evaluations further support the stock price increase. Source: Reuters Industry demand remains strong, driven by technology and manufacturing growth.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Freecast is up 61.90% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 23, FreeCast reached a nationwide distribution agreement with DIRECTV Multifamily, allowing FreeCast to promote and distribute DIRECTV streaming services in multi-family residences. This partnership expands FreeCast's influence in the multi-family sector, driving the stock price up.
</li>
<li>
On April 22, FreeCast signed a $5 million convertible promissory note extension agreement with Nextelligence. This financial arrangement has enhanced the company's liquidity, boosting market confidence.
</li>
<li>
On April 21, FreeCast released important company information through the EDGAR system, further increasing market attention on its business developments
The demand for multi-family housing market is growing, driving the expansion of related services.
</li>
</ol>
iTonic is up 41.99% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 24, Nasdaq approved iTonic Holdings' request, granting a 180-day extension to meet the minimum closing price requirement. This news boosted market confidence and significantly drove up the stock price.
</li>
<li>
On April 23, iTonic Holdings announced progress in its treatment planning system, further enhancing investor confidence in the company's future development.
</li>
<li>
On April 21, iTonic Holdings received notification that the initial compliance period had expired, extending the deadline to October 19. This move avoided potential delisting risks and stabilized the stock price. There is a noticeable increase in market demand for medical solutions and significant capital inflow.
</li>
</ol>
MaxLinear is up 35.77% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 24, MaxLinear announced its first-quarter financial report, with revenue increasing by 43% year-over-year to $137.19 million, exceeding market expectations of $135 million. Adjusted earnings per share were 22 cents, reversing last year's loss and surpassing the expected 18 cents. This performance drove the stock price up. Source: Reuters
</li>
<li>
On April 24, the company projected second-quarter revenue to be between $160 million and $170 million, far exceeding analysts' expectations of $137.45 million. Strong demand for optical data center products is the main driver of growth. Source: Benzinga
</li>
<li>
On April 24, demand for MaxLinear's optical connectivity solutions in the hyperscale AI and cloud platform market has increased, becoming the company's largest and fastest-growing end market. Source: TipRanks The semiconductor industry as a whole is performing strongly, with significant capital inflow
</li>
</ol>

SILO

Silo Pharma pre-market down 9.21%; Comfort Systems USA pre-market up 7.29%; Freecast pre-market up 61.90%; iTonic pre-market up 41.99%; MaxLinear pre-market up 35.77%

Pre-market hot trades in US stocks: Silo Pharma pre-market down 9.21%; Comfort Systems USA pre-market up 7.29%